IGF2 and sarcopenia: This paradox can be easily understood and resolved based on our H19-IGF2 findings, as young adults display the early phase of growth due to FTO-m6A-H19-IGF2-insulin signaling, whereas the elderly manifest with sarcopenia in the later phase due to excessive insulin signaling and insulin resistance.